Luigi Mangione, 28, is accused of murdering UnitedHealthcare CEO Brian Thompson, 50, on December 4, 2024, outside a Midtown Manhattan hotel during an investor conference [1, 2, 3, 4, 5, 6]. Mangione was arrested several days later at a McDonald's in Pennsylvania [1, 2, 6].
He faces New York state murder charges along with federal stalking charges linked to Thompson's killing [2, 3, 5, 6]. Jury selection for Mangione's state trial is set to begin September 8, 2026 [1, 2, 4, 5, 6]. Due to concerns over harassment or intimidation, a New York state judge ruled the jury will remain anonymous [4].
The intense public and media interest has led to plans for an overflow courtroom to accommodate journalists and members of the public at the state trial [4]. However, Mangione's defense has disputed the state court's media access plans, alleging the press and public have been unfairly excluded from the November jury selection process. They also claim court officials and prosecutors improperly influenced seating arrangements for reporters, though media reports and prosecutors deny these allegations [1, 2].
Federal prosecutors and defense lawyers have jointly requested a pretrial hearing on August 14, 2026, in Manhattan federal court where Mangione is expected to enter a guilty plea on stalking charges related to the case [3, 5, 6]. If Mangione pleads guilty, prosecutors will recommend a life prison sentence [3]. The plea deal is not finalized and could still fall apart, officials say [3].
Mangione’s attorneys may argue the federal stalking plea bars the state murder prosecution on double jeopardy grounds [5]. Several serious federal charges that carried the possibility of the death penalty were dismissed earlier, reducing Mangione’s capital punishment risks [5, 6]. Chicago criminal defense attorney Donna Rotunno noted, "Rarely somebody with no background, who’s educated, gets the maximum sentences. Is he looking at minimum sentences? No. But at the end of the day, he’s benefiting from more serious charges being dismissed" [6].
Prosecutors plan to introduce extensive evidence at the state trial, including surveillance footage, DNA samples, a 3D-printed gun, and a notebook allegedly written by Mangione [4]. Ammunition linked to the shooting was found to bear the words "delay," "deny," and "depose," reflecting criticism of the insurance industry [4].
Mangione's New York state trial remains scheduled to start with jury selection on September 8, after the federal hearing on August 14 or 15 [1, 2, 4, 5, 6].
